Back to search
Hyperphosphatemia Patients on Hemodialysis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hyperphosphatemia Patients on Hemodialysis trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Hyperphosphatemia Patients on Hemodialysis trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
An open-label, single-arm clinical study of TS-172 in hyperphosphatemia patients on hemodialysis
A phase 3, randomized, placebo-controlled, double-blind, phosphate binder-combination study of TS-172 in hyperphosphatemia patients on hemodialysis
A clinical study to evaluate the long-term safety and efficacy of TS-172 in hyperphosphatemia patients on hemodialysis.
A Phase 2a, Multicenter, Randomized, Open-label, Active Drug-controlled Trial to Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patie…
A phase 3, randomized, placebo-controlled, double-blind study of TS-172 in hyperphosphatemia
Raised phosphate levels in the blood (hyperphosphatemia) are frequently observed in hemodialysis patients with chronic kidney failure. In addition to increasing…